Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
RYR3
Introduction
Ryanodine receptor 3 is a protein that in humans is encoded by the RYR3 gene.[1] The protein encoded by this gene is both a calcium channel and a receptor for the plant alkaloid ryanodine. RYR3 and RYR1 control the resting calcium ion concentration in skeletal muscle.[2]
References
References
- ↑ Sorrentino V, Giannini G, Malzac P, Mattei MG (Feb 1994). “Localization of a novel ryanodine receptor gene (RYR3) to human chromosome 15q14-q15 by in situ hybridization”. Genomics. 18 (1): 163–5. doi:10.1006/geno.1993.1446. PMID 8276408.
- ↑ Perez CF, López JR, Allen PD (March 2005). “Expression levels of RyR1 and RyR3 control resting free Ca2+ in skeletal muscle”. Am. J. Physiol., Cell Physiol. 288 (3): C640–9. doi:10.1152/ajpcell.00407.2004. PMID 15548569.
Further reading
Further reading
- Bertocchini F, Ovitt CE, Conti A, et al. (1997). “Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles”. EMBO J. 16 (23): 6956–63. doi:10.1093/emboj/16.23.6956. PMC 1170299. PMID 9384575.
- Bultynck G, De Smet P, Rossi D, et al. (2001). “Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor”. Biochem. J. 354 (Pt 2): 413–22. doi:10.1042/bj3540413. PMC 1221670. PMID 11171121.
- Schwarzmann N, Kunerth S, Weber K, et al. (2002). “Knock-down of the type 3 ryanodine receptor impairs sustained Ca2+ signaling via the T cell receptor/CD3 complex”. J. Biol. Chem. 277 (52): 50636–42. doi:10.1074/jbc.M209061200. PMID 12354756.
- Nakashima Y, Nishimura S, Maeda A, et al. (1997). “Molecular cloning and characterization of a human brain ryanodine receptor”. FEBS Lett. 417 (1): 157–62. doi:10.1016/S0014-5793(97)01275-1. PMID 9395096.
- Xiao B, Masumiya H, Jiang D, et al. (2002). “Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors)”. J. Biol. Chem. 277 (44): 41778–85. doi:10.1074/jbc.M208210200. PMID 12213830.
- Davis MR, Haan E, Jungbluth H, et al. (2003). “Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene”. Neuromuscul. Disord. 13 (2): 151–7. doi:10.1016/S0960-8966(02)00218-3. PMID 12565913.
- Kitahara K, Kawa S, Katsuyama Y, et al. (2008). “Microsatellite scan identifies new candidate genes for susceptibility to alcoholic chronic pancreatitis in Japanese patients”. Dis. Markers. 25 (3): 175–80. doi:10.1155/2008/426764. PMC 3827802. PMID 19096130.
- Tochigi M, Kato C, Ohashi J, et al. (2008). “No association between the ryanodine receptor 3 gene and autism in a Japanese population”. Psychiatry Clin. Neurosci. 62 (3): 341–4. doi:10.1111/j.1440-1819.2008.01802.x. PMID 18588595.
- Masumiya H, Yamamoto H, Hemberger M, et al. (2003). “The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors”. FEBS Lett. 553 (1–2): 141–4. doi:10.1016/S0014-5793(03)00999-2. PMID 14550562.
- Jiang D, Xiao B, Li X, Chen SR (2003). “Smooth muscle tissues express a major dominant negative splice variant of the type 3 Ca2+ release channel (ryanodine receptor)”. J. Biol. Chem. 278 (7): 4763–9. doi:10.1074/jbc.M210410200. PMID 12471029.
- Mohaupt MG, Karas RH, Babiychuk EB, et al. (2009). “Association between statin-associated myopathy and skeletal muscle damage”. Canadian Medical Association Journal. 181 (1–2): E11–8. doi:10.1503/cmaj.081785. PMC 2704421. PMID 19581603.
- Balschun D, Wolfer DP, Bertocchini F, et al. (1999). “Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning”. EMBO J. 18 (19): 5264–73. doi:10.1093/emboj/18.19.5264. PMC 1171597. PMID 10508160.
- Martin C, Chapman KE, Seckl JR, Ashley RH (1998). “Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum”. Neuroscience. 85 (1): 205–16. doi:10.1016/S0306-4522(97)00612-X. PMID 9607712.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Van Acker K, Bultynck G, Rossi D, et al. (2004). “The 12 kDa FK506-binding protein, FKBP12, modulates the Ca(2+)-flux properties of the type-3 ryanodine receptor”. J. Cell Sci. 117 (Pt 7): 1129–37. doi:10.1242/jcs.00948. PMID 14970260.
- Bultynck G, Rossi D, Callewaert G, et al. (2001). “The conserved sites for the FK506-binding proteins in ryanodine receptors and inositol 1,4,5-trisphosphate receptors are structurally and functionally different”. J. Biol. Chem. 276 (50): 47715–24. doi:10.1074/jbc.M106573200. PMID 11598113.
- Leeb T, Brenig B (1998). “cDNA cloning and sequencing of the human ryanodine receptor type 3 (RYR3) reveals a novel alternative splice site in the RYR3 gene”. FEBS Lett. 423 (3): 367–70. doi:10.1016/S0014-5793(98)00124-0. PMID 9515741.
- Lynn S, Morgan JM, Lamb HK, et al. (1995). “Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle”. FEBS Lett. 372 (1): 6–12. doi:10.1016/0014-5793(95)00924-X. PMID 7556644.
External links
External links
- RYR3+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)